Lupagen is a privately held early stage biotech company developing first-in-class bedside enabled cell & gene therapies (CAR-T cell, gene editing and immunotherapy products) based on their patent-pending bedside point-of-care C> production and delivery platform.
Lupagen’s systems are deployed using standard apheresis-based platform customized for a diverse range of gene therapies that require targeted genetic or cellular modification of selective populations of a patient’s circulating peripheral blood mononuclear cells.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 8951 Cypress Waters Blvd, Dallas,texas 75019,united States
- Industry
- Biotechnology
- Website
- lupagen.com
- Keywords
- Biotechnology, Cell therapy, Gene therapy, Immunotherapy, Oncology, Rare Disease, Autoimmune.
- HQ
- Dallas, Texas
Lupagen Questions
Lupagen's website is lupagen.com
Lupagen's LinkedIn profile is https://www.linkedin.com/company/billingegroup.com
Lupagen has
3 employees.
View email and phone details for 3
employees at Lupagen.
Lupagen's industry is
Biotechnology
Lupagen's top competitors are
Mesenbio,
Genprex, Inc.,
Instil Bio,
Chan Zuckerberg Biohub Network,
Lumos Pharma,
Avero Diagnostics,
Lantern Pharma Inc. (Nasdaq: Ltrn),
Beam Therapeutics,
Nanocell Therapeutics,
Alaya.bio.
Lupagen's categories are Biotechnology
Lupagen's founding year is 2017
